1. Home
  2. EOLS vs FFWM Comparison

EOLS vs FFWM Comparison

Compare EOLS & FFWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • FFWM
  • Stock Information
  • Founded
  • EOLS 2012
  • FFWM 1990
  • Country
  • EOLS United States
  • FFWM United States
  • Employees
  • EOLS N/A
  • FFWM N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • FFWM Major Banks
  • Sector
  • EOLS Health Care
  • FFWM Finance
  • Exchange
  • EOLS Nasdaq
  • FFWM Nasdaq
  • Market Cap
  • EOLS 493.5M
  • FFWM 406.2M
  • IPO Year
  • EOLS 2018
  • FFWM 2014
  • Fundamental
  • Price
  • EOLS $7.66
  • FFWM $6.09
  • Analyst Decision
  • EOLS Strong Buy
  • FFWM Buy
  • Analyst Count
  • EOLS 5
  • FFWM 2
  • Target Price
  • EOLS $21.25
  • FFWM $6.25
  • AVG Volume (30 Days)
  • EOLS 1.2M
  • FFWM 612.7K
  • Earning Date
  • EOLS 11-05-2025
  • FFWM 10-28-2025
  • Dividend Yield
  • EOLS N/A
  • FFWM N/A
  • EPS Growth
  • EOLS N/A
  • FFWM N/A
  • EPS
  • EOLS N/A
  • FFWM N/A
  • Revenue
  • EOLS $277,941,000.00
  • FFWM $104,325,000.00
  • Revenue This Year
  • EOLS $14.01
  • FFWM $164.53
  • Revenue Next Year
  • EOLS $29.46
  • FFWM $9.97
  • P/E Ratio
  • EOLS N/A
  • FFWM N/A
  • Revenue Growth
  • EOLS 17.15
  • FFWM N/A
  • 52 Week Low
  • EOLS $5.71
  • FFWM $4.42
  • 52 Week High
  • EOLS $17.82
  • FFWM $8.52
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 50.21
  • FFWM 69.19
  • Support Level
  • EOLS $7.19
  • FFWM $5.80
  • Resistance Level
  • EOLS $7.67
  • FFWM $6.00
  • Average True Range (ATR)
  • EOLS 0.34
  • FFWM 0.18
  • MACD
  • EOLS 0.13
  • FFWM 0.04
  • Stochastic Oscillator
  • EOLS 79.29
  • FFWM 86.10

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About FFWM First Foundation Inc.

First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.

Share on Social Networks: